Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 8
2003 6
2004 11
2005 3
2006 7
2007 7
2008 9
2009 10
2010 12
2011 5
2012 11
2013 5
2014 6
2015 12
2016 4
2017 13
2018 11
2019 11
2020 9
2021 25
2022 14
2023 12
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

197 results

Results by year

Filters applied: . Clear all
Page 1
Bladder Preservation With Twice-a-Day Radiation Plus Fluorouracil/Cisplatin or Once Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer: NRG/RTOG 0712-A Randomized Phase II Trial.
Coen JJ, Zhang P, Saylor PJ, Lee CT, Wu CL, Parker W, Lautenschlaeger T, Zietman AL, Efstathiou JA, Jani AB, Kucuk O, Souhami L, Rodgers JP, Sandler HM, Shipley WU. Coen JJ, et al. Among authors: kucuk o. J Clin Oncol. 2019 Jan 1;37(1):44-51. doi: 10.1200/JCO.18.00537. Epub 2018 Nov 15. J Clin Oncol. 2019. PMID: 30433852 Free PMC article. Clinical Trial.
Cancer biomarkers.
Kucuk O. Kucuk O. Mol Aspects Med. 2015 Nov;45:1-2. doi: 10.1016/j.mam.2015.07.003. Epub 2015 Jul 14. Mol Aspects Med. 2015. PMID: 26187107 No abstract available.
Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer: The VIABLE Phase 3 Randomized Clinical Trial.
Vogelzang NJ, Beer TM, Gerritsen W, Oudard S, Wiechno P, Kukielka-Budny B, Samal V, Hajek J, Feyerabend S, Khoo V, Stenzl A, Csöszi T, Filipovic Z, Goncalves F, Prokhorov A, Cheung E, Hussain A, Sousa N, Bahl A, Hussain S, Fricke H, Kadlecova P, Scheiner T, Korolkiewicz RP, Bartunkova J, Spisek R; VIABLE Investigators. Vogelzang NJ, et al. JAMA Oncol. 2022 Apr 1;8(4):546-552. doi: 10.1001/jamaoncol.2021.7298. JAMA Oncol. 2022. PMID: 35142815 Free PMC article. Clinical Trial.
Walk More, Eat Less, Don't Stress.
Kucuk O. Kucuk O. Cancer Epidemiol Biomarkers Prev. 2022 Sep 2;31(9):1673-1674. doi: 10.1158/1055-9965.EPI-22-0609. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 36052489
EDITORIAL COMMENT.
Kucuk O. Kucuk O. Urology. 2021 Oct;156:209-210. doi: 10.1016/j.urology.2021.05.091. Urology. 2021. PMID: 34758559 No abstract available.
Is vitamin A an antioxidant?
Bohn T, Böhm V, Dulińska-Litewka J, Landrier JF, Bánáti D, Kucuk O, Borel P, Canas JA, Rühl R. Bohn T, et al. Among authors: kucuk o. Int J Vitam Nutr Res. 2023 Dec;93(6):481-482. doi: 10.1024/0300-9831/a000752. Epub 2022 Mar 16. Int J Vitam Nutr Res. 2023. PMID: 35291873 Free article. No abstract available.
Soy foods, isoflavones, and breast cancer.
Kucuk O. Kucuk O. Cancer. 2017 Jun 1;123(11):1901-1903. doi: 10.1002/cncr.30614. Epub 2017 Mar 6. Cancer. 2017. PMID: 28263364 Free article. No abstract available.
C-reactive protein in urologic cancers.
Huang J, Baum Y, Alemozaffar M, Ogan K, Harris W, Kucuk O, Master VA. Huang J, et al. Among authors: kucuk o. Mol Aspects Med. 2015 Nov;45:28-36. doi: 10.1016/j.mam.2015.04.001. Epub 2015 Apr 29. Mol Aspects Med. 2015. PMID: 25936279 Review.
Cancer chemoprevention.
Kucuk O. Kucuk O. Cancer Metastasis Rev. 2002;21(3-4):189-97. doi: 10.1023/a:1021298508095. Cancer Metastasis Rev. 2002. PMID: 12549760 Review.
Lycopene and chemotherapy toxicity.
Sahin K, Sahin N, Kucuk O. Sahin K, et al. Among authors: kucuk o. Nutr Cancer. 2010;62(7):988-95. doi: 10.1080/01635581.2010.509838. Nutr Cancer. 2010. PMID: 20924974 Review.
197 results